Evidence used
- No CISA KEV confirmation is currently recorded.
- A structured source references public exploit or proof-of-concept material.
- EPSS is 2.60% for the current model date.
BlackTreeCVE IntelligenceUnknown · Unknown
High technical severity with public exploit material referenced by a structured source; prioritise exposed affected systems while verifying vendor guidance.
High technical severity with public exploit material referenced by a structured source; prioritise exposed affected systems while verifying vendor guidance.
Fix not verifiedAn issue was discovered on Securifi Almond, Almond+, and Almond 2015 devices with firmware AL-R096. The device provides a user with the capability of executing various actions on the web management interface. It seems that the device does not implement any Origin header check which allows an attacker who can trick a user to navigate to an attacker's webpage to exploit this issue and brute force the password for the web management interface. It also allows an attacker to then execute any other actions which include management if rules, sensors attached to the devices using the websocket requests.
An issue was discovered on Securifi Almond, Almond+, and Almond 2015 devices with firmware AL-R096. The device provides a user with the capability of executing various actions on the web management interface. It seems that the device does not implement any Origin header check which allows an attacker who can trick a user to navigate to an attacker's webpage to exploit this issue and brute force the password for the web management interface. It also allows an attacker to then execute any other actions which include management if rules, sensors attached to the devices using the websocket requests.
The product exposes sensitive information to an actor that is not explicitly authorized to have access to that information.
An attacker operating through a network path may attempt exploitation without authentication after a user interaction. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
An issue was discovered on Securifi Almond, Almond+, and Almond 2015 devices with firmware AL-R096. The device provides a user with the capability of executing various actions on the web management interface. It seems that the device does not implement any Origin header check which allows an attacker who can trick a user to navigate to an attacker's webpage to exploit this issue and brute force the password for the web management interface. It also allows an attacker to then execute any other actions which include management if rules, sensors attached to the devices using the websocket requests.
The product exposes sensitive information to an actor that is not explicitly authorized to have access to that information.
An attacker operating through a network path may attempt exploitation without authentication after a user interaction. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
CVSS severity, EPSS forecast probability, public exploit material and CISA-confirmed exploitation are separate signals.
No CISA KEV match was present at the last successful refresh. This means no confirmation from that source, not proof of no exploitation.
A structured CVE source labels at least one public reference as exploit material. BlackTree has not independently validated that it is safe, reliable or weaponised.
CWE-200: Exposure of Sensitive Information to an Unauthorized Actor. The product exposes sensitive information to an actor that is not explicitly authorized to have access to that information.
CVSS:3.0/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:HCommon Vulnerability Scoring System 3.0: the compact vector below is decoded into plain language.
Operational remediation based on structured source evidence.
Published 18 Jun 2019 · Last source change 5 Aug 2024, 16:34 UTC · CWE-200 · Exposure of Sensitive Information to an Unauthorized Actor
Missing structured fields: affected product. Missing data is not evidence of low risk; review the primary advisory.